Breaking News
Josh Brumm
About Josh Brumm
Biotech Chief Executive Officer. Two approved drugs on the market, raised ~$1.5Bn in capital including taking four companies public. Passionate about leadership, driven by teamwork and committed to winning for patients and creating value for stakeholders.